Wells Fargo & Company Oragenics Inc Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.11 - $15.59 $2 - $405	26 Added 3.36%	799 $0
Q3 2022 Nov 14, 2022	SELL	$0.23 - $14.18 $1 - $85	-6 Reduced 0.77%	773 $0
Q2 2022 Aug 12, 2022	BUY	$0.24 - $0.42 $15 - $26	63 Added 8.8%	779 $0
Q1 2022 May 16, 2022	BUY	$0.33 - $0.56 $0 - $1	2 Added 0.28%	716 $0
Q4 2021 Feb 14, 2022	BUY	$0.43 - $0.69 $2 - $3	5 Added 0.71%	714 $0
Q3 2021 Nov 15, 2021	BUY	$0.58 - $0.84 $44 - $64	77 Added 12.18%	709 $0
Q2 2021 Aug 16, 2021	BUY	$0.6 - $0.89 $18 - $26	30 Added 4.98%	632 $0
Q1 2021 May 13, 2021	BUY	$0.52 - $1.52 $114 - $334	220 Added 57.59%	602 $1,000
Q4 2020 Feb 09, 2021	BUY	$0.39 - $0.6 $56 - $86	144 Added 60.5%	382 $0
Q3 2020 Nov 05, 2020	SELL	$0.56 - $1.49 $0 - $1	-1 Reduced 0.42%	238 $0
Q2 2020 Aug 13, 2020	BUY	$0.39 - $0.83 $0 - $1	2 Added 0.84%	239 $0
Q1 2020 May 14, 2020	BUY	$0.43 - $0.75 $101 - $177	237 New	237 $0

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $41.9M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.